Eric is our Vice President of Development and Operations. He has a strong multidisciplinary background in metabolic disease and oncology targets with over 25 years of experience in the biotech/pharmaceutical industry. Prior to joining Metacrine, Eric served as senior director of operations and contracts at Seragon Pharmaceuticals. At Seragon he was involved in business development efforts resulting in the acquisition of Seragon by Genentech. Prior to Seragon, Eric served as director of operations at Aragon Pharmaceuticals and as a pharmacologist at X-Ceptor Therapeutics, Ligand Pharmaceuticals and Hybritech, Inc. He received his B.S. in biology from the University of California, San Diego.